By dissecting metabolic and epigenetic features imposed by ageing in cardiomyocyte conversion from fetal and adult mouse fibroblasts, Santos et al. describe that metabolic modulation can enhance direct cardiac reprogramming.
Get full access to this article
View all access options for this article.
References
1.
BaysHE, KulkarniA, GermanC, et al.Ten things to know about ten cardiovascular disease risk factors—2022. Am J Prev Cardiol, 2022; 10:100342; doi: 10.1016/j.ajpc.2022.100342
2.
IntlekoferAM, FinleyLWS. Metabolic signatures of cancer cells and stem cells. Nat Metab, 2019; 1(2):177–188; doi: 10.1038/s42255-019-0032-0
3.
JebranAF, SeidlerT, TiburcyM, et al.Engineered heart muscle allografts for heart repair in primates and humans. Nature, 2025; 639(8054):503–511; doi: 10.1038/s41586-024-08463-0
4.
SantosF, CorreiaM, DiasR, et al.Age‐associated metabolic and epigenetic barriers during direct reprogramming of mouse fibroblasts into induced cardiomyocytes. Aging Cell, 2025; 24(2):e14371; doi: 10.1111/acel.14371
5.
SinghVP, PinnamaneniJP, PugazenthiA, et al.Enhanced generation of induced cardiomyocytes using a small‐molecule cocktail to overcome barriers to cardiac cellular reprogramming. JAHA, 2020; 9(12):e015686; doi: 10.1161/JAHA.119.01568
6.
WangH, YangY, LiuJ, et al.Direct cell reprogramming: Approaches, mechanisms and progress. Nat Rev Mol Cell Biol, 2021; 22(6):410–424; doi: 10.1038/s41580-021-00335-z
7.
XieY, LiuJ, QianL. Direct cardiac reprogramming comes of age: Recent advance and remaining challenges. Semin Cell Dev Biol, 2022; 122:37–43; doi: 10.1016/j.semcdb.2021.07.010
8.
ZhuX, ChenZ, ShenW, et al.Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: The regulation and intervention. Signal Transduct Target Ther, 2021; 6(1):245; doi: 10.1038/s41392-021-00646-9
